Erythromycin: Broad-Spectrum Antibiotic for Bacterial Infection Control
Erythromycin
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.54 | $49.00 (0%) | 🛒 Add to cart |
| 120 | $0.50 | $65.33 $60.00 (8%) | 🛒 Add to cart |
| 180 | $0.47 | $98.00 $84.00 (14%) | 🛒 Add to cart |
| 270 | $0.44 | $147.00 $118.00 (20%) | 🛒 Add to cart |
| 360 | $0.42
Best per pill | $196.00 $153.00 (22%) | 🛒 Add to cart |
Erythromycin is a macrolide-class antibiotic with established efficacy against a wide range of gram-positive and some gram-negative bacteria. It functions by inhibiting bacterial protein synthesis, effectively halting microbial replication. This agent is particularly valuable for patients with penicillin allergies and remains a cornerstone in treating respiratory, skin, and soft tissue infections. Its well-documented pharmacokinetic profile and multiple formulation options support tailored therapeutic approaches across diverse patient populations.
Features
- Belongs to the macrolide antibiotic class
- Available in oral (tablet, capsule, suspension), topical, and ophthalmic formulations
- Bacteriostatic action through 50S ribosomal subunit binding
- Effective against Streptococcus, Staphylococcus, Mycoplasma, and Chlamydia species
- Multiple ester forms (e.g., ethylsuccinate, stearate) for optimized absorption
Benefits
- Provides a reliable alternative for penicillin-allergic patients
- Covers common community-acquired respiratory pathogens
- Demonstrates anti-inflammatory properties in certain dermatological applications
- Offers flexible dosing regimens across age groups
- Well-established safety profile with decades of clinical use
- Available in cost-effective generic formulations
Common use
Erythromycin is indicated for the treatment of various bacterial infections including pharyngitis, tonsillitis, acute otitis media, community-acquired pneumonia, and skin/soft tissue infections such as erysipelas and cellulitis. It is also used for pertussis prophylaxis, Legionnaires’ disease, chlamydial infections, and as part of Helicobacter pylori eradication regimens. Off-label uses include acne vulgaris management and gastrointestinal motility enhancement.
Dosage and direction
Adults: Typical dosage ranges from 250-500 mg orally every 6-12 hours, depending on infection severity and formulation. For severe infections: 4 grams daily in divided doses.
Children: 30-50 mg/kg/day in divided doses every 6-8 hours.
Topical: Apply to affected area twice daily after cleansing.
Ophthalmic: ½ inch ribbon applied to conjunctival sac up to 6 times daily.
Take oral forms on an empty stomach (1 hour before or 2 hours after meals) with a full glass of water, unless using enteric-coated tablets. Complete the full prescribed course even if symptoms improve.
Precautions
Use with caution in patients with hepatic impairment due to extensive liver metabolism. Monitor liver function tests during prolonged therapy. May prolong QT interval; assess cardiac risk factors before initiation. Superinfections with nonsusceptible organisms may occur. Not recommended for meningitis treatment due to inadequate cerebrospinal fluid penetration. Use during pregnancy only if clearly needed (Category B). Excreted in breast milk; consider temporary discontinuation of nursing.
Contraindications
Hypersensitivity to erythromycin or other macrolide antibiotics. Concurrent administration with ergot derivatives, cisapride, pimozide, or terfenadine. Patients with known history of QT prolongation or ventricular arrhythmias. Severe hepatic impairment. History of cholestatic jaundice/hepatic dysfunction with previous erythromycin use.
Possible side effect
Common: nausea, vomiting, abdominal cramping, diarrhea (including antibiotic-associated colitis).
Less common: rash, urticaria, transient hearing loss (high doses), hepatic enzyme elevations.
Rare: QT prolongation, ventricular tachycardia, cholestatic jaundice, pseudomembranous colitis, anaphylaxis.
Topical: burning, itching, dryness, peeling at application site.
Ophthalmic: transient irritation, blurred vision, hypersensitivity reactions.
Drug interaction
Significant interactions with:
- CYP3A4 substrates (increased levels of simvastatin, lovastatin, carbamazepine)
- Anticoagulants (enhanced warfarin effect)
- Theophylline (increased serum concentrations)
- Digoxin (increased bioavailability)
- Colchicine (increased toxicity risk)
- Ergot alkaloids (risk of ergotism)
- Sildenafil (increased exposure)
- Cyclosporine (increased nephrotoxicity risk)
Missed dose
Take the missed dose as soon as remembered. If it is nearly time for the next dose, skip the missed dose and resume regular schedule. Do not double doses to make up for a missed dose. Maintaining consistent antibiotic levels is important for efficacy, but single missed doses rarely significantly impact overall treatment outcome.
Overdose
Symptoms may include severe nausea, vomiting, diarrhea, hearing loss, and pancreatitis. Management is supportive: gastric lavage if recent ingestion, symptomatic treatment, and monitoring of electrolyte balance. Hemodialysis is not effective for removal. Specific antidotes are not available. Contact poison control center (1-800-222-1222) for guidance.
Storage
Store at room temperature (15-30°C/59-86°F) in original container. Keep away from moisture, light, and excessive heat. Do not freeze liquid formulations. Shake suspensions well before use. Discard unused oral suspension after 14 days. Keep all medications out of reach of children and pets.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting, stopping, or changing any medication regimen. The prescribing physician should make final determinations regarding appropriate therapy based on individual patient factors, current guidelines, and clinical judgment.
Reviews
“Erythromycin remains a valuable tool in our antimicrobial arsenal, particularly for penicillin-allergic patients. Its predictable spectrum and generally favorable tolerability profile make it a first-line choice for many community-acquired infections.” - Infectious Disease Specialist, 15 years experience
“While newer macrolides have emerged, erythromycin’s cost-effectiveness and proven history maintain its relevance in appropriate clinical scenarios. Gastrointestinal side effects can be limiting but are often manageable with dose adjustment or formulation selection.” - Clinical Pharmacologist, 12 years experience
“The topical formulation provides excellent efficacy in inflammatory acne with minimal systemic exposure. Patients appreciate having a non-antibiotic alternative that avoids tetracycline-related photosensitivity concerns.” - Dermatologist, 8 years experience